Interferon-Stimulated Genes are Transcriptionally Repressed by PR in Breast Cancer

Keywords

Cancer research, Biology, Gene knockdown, Psychological repression, Transcriptional regulation

References

• Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironmentRobert Tolksdorf — 2017
• Estrogen control of progesterone receptor induction in human breast cancer: role of nuclear estrogen receptor.Kathryn B. Horwitz, William McGuire — 1979
• Enhanced Tumor Development in Mice Lacking a Functional Type I Interferon ReceptorSandrine Picaud, Boris Bardot, Edward De Maeyer — 2002
• New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.Carol A. Sartorius, Steve D. Groshong, Louise A. Miller — 1994
• An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survivalAntoine M. Snijders, Sasha A. Langley, Jian‐Hua Mao — 2014
• Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escapeBradley N. Bidwell, Clare Y. Slaney, Nimali P. Withana — 2012
• Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexesAndrea R. Daniel, Angela L. Gaviglio, Todd P. Knutson — 2014
• Scaffolding actions of membrane-associated progesterone receptorsChristy R. Hagan, Emily J. Faivre, Carol A. Lange — 2008
• Role of Phosphorylation in Progesterone Receptor Signaling and SpecificityChristy R. Hagan, Andrea R. Daniel, Gwen E. Dressing — 2011
• Estrogen receptor target gene: an evolving concept.Jason S. Carroll, Myles Brown — 2006
• Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.Lin Tung — 1993
• Insights into Negative Regulation by the Glucocorticoid Receptor from Genome-Wide Profiling of Inflammatory CistromesN. Henriette Uhlenhaut, Grant D. Barish, Ruth T. Yu — 2012
• Architecture of the human regulatory network derived from ENCODE dataMark Gerstein, Anshul Kundaje, Manoj Hariharan — 2012
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionRobert D. Schreiber, Lloyd J. Old, Mark J. Smyth — 2011
• A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cellsChristy R. Hagan, Todd P. Knutson, Carol A. Lange — 2013
• Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes.Nagesha Rao, Melysia T. McCalman, Panagiotis Moulos — 2011
• Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortiumJie Wang, Jiali Zhuang, Sowmya Iyer — 2012
• An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerRalph R. Weichselbaum, Hemant Ishwaran, Taewon Yoon — 2008
• Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2*Barbara Testoni, Christine Völlenkle, Francesca Guerrieri — 2011
• Progesterone signalling in breast cancer: a neglected hormone coming into the limelightCathrin Brisken — 2013

Cited by

• O-GlcNAc-dependent regulation of progesterone receptor function in breast cancerGloria M. Trinca, Merit L. Goodman, Evangelia K. Papachristou — 2017
• Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functionsCecilia J. Proietti, Mauro E. Cenciarini, Patricia V. Elizalde — 2018
• Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicingTianbao Li, Qi Liu, Nick Garza — 2018
• Progesterone Receptor Attenuates STAT1-Mediated Interferon Signaling in Breast CancerMerit L. Goodman, Gloria M. Trinca, K. Walter — 2019
• Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic VirotherapyNadiia Lypova, Lilibeth Lanceta, Alana Gipson — 2019
• Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathwayYanjun Gao, Shanhui Liu, Qi Guo — 2019
• Effect of Bazedoxifene and Conjugated Estrogen (Duavee®) on Breast Cancer Risk Biomarkers in High Risk Women: A Pilot StudyCarol J. Fabian, Lauren Nye, Kandy R. Powers — 2019
• The eIF2α kinase GCN2 modulates period and rhythmicity of the circadian clock by translational control of Atf4Salil Saurav Pathak, Dong Liu, Tianbao Li — 2019
• Molecular mechanisms underlying progesterone receptor action in breast cancer: insights into cell proliferation and stem cell regulation.Mauro E. Cenciarini, Cecilia J. Proietti — 2019
• Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone AcetateOukseub Lee, Megan Sullivan, Yanfei Xu — 2019
• MX2 is a novel regulator of cell cycle in melanoma cellsMarina Juraleviciute, Joanna Poźniak, Jérémie Nsengimana — 2019
• Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancerK. Walter, Justin M. Balko, Christy R. Hagan — 2020
• Reciprocal fine-tuning of progesterone and prolactin-regulated gene expression in breast cancer cellsSean M. Holloran, Bakhtiyor Nosirov, K. Walter — 2020
• KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrityRomi Gupta, Parmanand Malvi, Keshab R. Parajuli — 2020
• Progesterone and Progesterone Receptors in Breast Cancer: Past, Present, FutureKathryn B. Horwitz, Carol A. Sartorius — 2020
• Type I interferons and related pathways in cell senescenceSteven M. Frisch, Ian MacFawn — 2020
• The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathwayRilin Deng, Chaohui Zuo, Yongqi Li — 2020
• Progesterone promotes immunomodulation and tumor development in the murine mammary glandLauryn R. Werner, Katelin A. Gibson, Merit L. Goodman — 2021
• UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNAR signaling axisHera Kim, Yashwanth Subbannayya, Fiachra Humphries — 2021
• Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT AxisLewis Z. Shi, James A. Bonner — 2021

Related papers

• Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathwayHai Hu, Yanan Wang, Yan Dong — 2023
• Knockdown of ecdysteroid synthesis genes results in impaired molting and high mortality in Bactericera cockerelli (Hemiptera: Triozidae).Jorge R. Paredes‐Montero, Usman Arif, Judith K. Brown — 2022
• Supplementary Revised Figure S3 from MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53Imayavaramban Lakshmanan, Shereen Salfity, Parthasarathy Seshacharyulu — 2023
• Supplementary Revised Figure S3 from MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53Imayavaramban Lakshmanan, Shereen Salfity, Parthasarathy Seshacharyulu — 2023
• Supplementary Revised Figure S4 from MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53Imayavaramban Lakshmanan, Shereen Salfity, Parthasarathy Seshacharyulu — 2023
• Embryo-to-embryo variability in RNAi knockdown efficiency of dKDM5/lid in Drosophila melanogasterAshley Albright, Michael B. Eisen — 2021
• Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.Wei Xu, Chao Chen, Ruijun Xu — 2018
• Molecular basis of transient repression of beta-galactosidase in Escherichia coli.B Tyler, Boris Magasanik — 1969
• Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6Fushun Li, Xianghua Sun, Qing Liu — 2021
• How mammalian transcriptional repressors work.Gerald Thiel, Michael Lietz, Mathias Hohl — 2004